Vikram Sinai Talaulikar: Busy Weeks in Clinic: Reflections on Menopause Care
Vikram Sinai Talaulikar, Associate Specialist in Reproductive Medicine at UCLH and Hon, shared a post on LinkedIn:
“It has been busy few weeks of clinics and some reflections on the variations in advice we provide for menopause care.
A 54 year old who had stopped her periods for a year and was experiencing typical menopause symptoms presented to her healthcare provider. She had no background medical problems but was worried about the risk of breast cancer associated with oestrogen and progesterone use. She was counselled about the risk based on guidelines which suggested a risk with both oestrogen and progesterone part of HRT. She felt that the risk was not something she was comfortable with but did decide to seek an alternative opinion. This time she was presented with data and figures which suggested a reduced risk of breast cancer with oestrogen and slightly increased risk with the combination. She felt confused – who to believe!
Another woman who had considered systemic HRT for menopause at 55, less for symptoms but mainly for long-term health benefits was counselled by one healthcare professional about multiple benefits for long-term cognitive health, bone and cardiovascular health while another healthcare professional advised against HRT purely for long-team health benefits in absence of symptoms. She felt confused – who to believe!
A 45 year old woman saw her healthcare professional for symptoms suggestive of menopause and requested HRT but was advised against it as she continued to have monthly periods and she could put herself at a risk of excess hormones. She consulted an alternative provider who suggested that it was fine for her to start HRT and offered a prescription advising no such risks of excess hormones would apply to her. The woman felt confused – who to believe!
Yet another woman who had started continuous combined HRT for menopause in her 50s had started experienced bleeding in the 3rd month of initiating her HRT. She had had no bleeding for past 2 years. She saw her healthcare provider who referred her for an urgent ultrasound scan on a cancer pathway for postmenopausal bleeding. She was anxiously waiting for her scan appointment when another healthcare provider called her to cancel her scan and suggested that it was not uncommon to bleed in the first 6 months of starting HRT and that she no longer needs a scan now but a review later. She felt confused – who to believe!
There are even more examples. Navigating menopause care can be confusing for patients. We need to continue our efforts to support them in decision making based on the best possible scientific evidence we have and it can be challenging at times!”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 5, 2026, 16:36Christopher Robinson: The Role of Professional Obligations for Cesarean Delivery on Maternal Request
-
Jul 5, 2026, 16:30Does Endometrial Scratching Improve IVF Success? – Fertility Plus
-
Jul 5, 2026, 16:24Downloadable Conference Highlights Feature RBMO Editors at ESHRE 2026 – RBMO
-
Jul 5, 2026, 15:37Don’t Miss Tomorrow’s Keynote Session! – ESHRE
-
Jul 5, 2026, 15:29Ying Cheong: Another Thought-Provoking Session at the ESHRE 2026 By Kirsten Tryde Macklon
-
Jul 5, 2026, 15:21Age May Be a More Important Determinant of Egg Yield Than AMH – Fertility and Sterility
-
Jul 5, 2026, 15:14Kazem Nouri: Pleased to Speak on Fertility Preservation in Austria at the University Hospital Wiener Neustadt
-
Jul 5, 2026, 15:05Vasundara Jagannathan: Our Research Abstract Has Been Accepted for E-Poster Presentation at ASRM 2026
-
Jul 5, 2026, 14:58The PCOS Statistic Is Not 1 in 10, New Global Data Reveals the Truth – Fertility Plus
